ESTRO-ACROP在线MRI引导放疗系统质量保证与医学物理调试指南
共识明确了多数测试的重要性、推荐频率及对两种获批系统的适用性,旨在支持医学物理师安全使用该类系统。
要点
- 共识明确了各测试的重要性和推荐频率,优先关注与成像和追踪相关的项目。
- 调试阶段需重视工作流程定义等8个医学物理方面。
局限性
- 基于专家共识而非系统评价或临床试验证据。
- 仅针对两种获批临床使用的在线MRI引导放疗系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The goal of this consensus expert opinion was to define quality assurance (QA) tests for online magnetic resonance image (MRI) guided radiotherapy (oMRgRT) systems and to define the important medical physics aspects for installation and commissioning of an oMRgRT system.
MATERIALS AND METHODS: Ten medical physicists and two radiation oncologists experienced in oMRgRT participated in the survey. In the first round of the consensus expert opinion, ideas on QA and commissioning were collected. Only tests and aspects different from commissioning of a CT guided radiotherapy (RT) system were considered. In the following two rounds all twelve participants voted on the importance of the QA tests, their recommended frequency and their suitability for the two oMRgRT systems approved for clinical use as well as on the importance of the aspects to consider during medical physics commissioning.
RESULTS: Twenty-four QA tests were identified which are potentially important during commissioning and routine QA on oMRgRT systems compared to online CT guided RT systems. An additional eleven tasks and aspects related to construction, workflow development and training were collected. Consensus was found for most tests on their importance, their recommended frequency and their suitability for the two approved systems. In addition, eight aspects mostly related to the definition of workflows were also found to be important during commissioning.
CONCLUSIONS: A program for QA and commissioning of oMRgRT systems was developed to support medical physicists to prepare for safe handling of such systems.
引用
- Tanadini-Lang, Budgell, Bohoudi, et al. An ESTRO-ACROP guideline on quality assurance and medical physics commissioning of online MRI guided radiotherapy systems based on a consensus expert opinion. Radiother Oncol. 2023. PMID: 36736592. doi:10.1016/j.radonc.2023.109504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。